Cubist Systematic Strategies’s EyePoint Pharmaceuticals EYPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-99,498
| Closed | -$741K | – | 1720 |
|
|
2024
Q4 | $741K | Buy |
99,498
+67,527
| +211% | +$503K | ﹤0.01% | 884 |
|
|
2024
Q3 | $255K | Sell |
31,971
-444,279
| -93% | -$3.55M | ﹤0.01% | 1113 |
|
|
2024
Q2 | $4.14M | Buy |
476,250
+425,717
| +842% | +$3.7M | 0.03% | 385 |
|
|
2024
Q1 | $1.04M | Sell |
50,533
-3,489
| -6% | -$72.1K | 0.01% | 1131 |
|
|
2023
Q4 | $1.25M | Sell |
54,022
-81,137
| -60% | -$1.88M | 0.01% | 1005 |
|
|
2023
Q3 | $1.08M | Buy |
135,159
+100,980
| +295% | +$807K | 0.01% | 1021 |
|
|
2023
Q2 | $297K | Buy |
+34,179
| New | +$297K | ﹤0.01% | 1554 |
|
|
2023
Q1 | – | Sell |
-11,886
| Closed | -$41.6K | – | 2964 |
|
|
2022
Q4 | $41.6K | Sell |
11,886
-266
| -2% | -$931 | ﹤0.01% | 2968 |
|
|
2022
Q3 | $96K | Buy |
12,152
+5,552
| +84% | +$43.9K | ﹤0.01% | 3230 |
|
|
2022
Q2 | $52K | Buy |
6,600
+2,099
| +47% | +$16.5K | ﹤0.01% | 3549 |
|
|
2022
Q1 | $55K | Sell |
4,501
-3,208
| -42% | -$39.2K | ﹤0.01% | 3333 |
|
|
2021
Q4 | $94K | Buy |
+7,709
| New | +$94K | ﹤0.01% | 3212 |
|
|
2021
Q2 | – | Sell |
-19,243
| Closed | -$196K | – | 2962 |
|
|
2021
Q1 | $196K | Buy |
+19,243
| New | +$196K | ﹤0.01% | 2484 |
|